Vishwanathan, Ashwin
Sood, Alex
Wu, Jingpeng
Ramirez, Alexandro D.
Yang, Runzhe
Kemnitz, Nico
Ih, Dodam
Turner, Nicholas
Lee, Kisuk
Tartavull, Ignacio
Silversmith, William M.
Jordan, Chris S.
David, Celia
Bland, Doug
Sterling, Amy
Seung, H. Sebastian
Goldman, Mark S.
Aksay, Emre R. F.
,
Wille, Kyle
Silverman, Ben
Willie, Ryan
Morejohn, Sarah
Koolman, Selden
Sorek, Marissa
Jones, Devon
Sterling, Amy
David, Celia
Reddy, Sujata
Pelegrino, Anthony
Williams, Sarah
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY021581, EY027036, EY027017)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS104682)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA203710)
Article History
Received: 12 December 2022
Accepted: 11 September 2024
First Online: 22 November 2024
Competing interests
: H.S.S., N.K., D.I., N.T. and K.L. have financial interests in Zetta AI, LLC. The remaining authors declare no competing interests.